Lung Cancer, Not One Disease: Diverse Patients Need Personalized Treatments, Two New Studies Show
BURLINGTON, ON – “New research taking place right here on Canadian soil is shedding light on the nation's number one cancer killer,i lung cancer. Boehringer Ingelheim (Canada) Ltd. today announced data from Phase III clinical trials involving two different investigational oncology treatments - afatinib* and nintedanib* - in two distinct groups of patients with advanced non-small cell lung cancer (NSCLC). The research is further proof that lung cancer is not just one disease - it can affect anyone, not just smokers.”
FDA approves Roche diagnostic for gene mutation in lung cancer
(Reuters) – “U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs.”
Cancer survivor exudes calm in Legislature’s budget battles
Redmond Republican Andy Hill, the state Senate’s chief budget writer, learned a hard-won lesson when advanced lung cancer threatened his life four years ago. “The illness taught me not to sweat the small stuff,” he said.
OLYMPIA — “Republican state Sen. Andy Hill has a regular reminder of the advanced lung cancer that threatened his life four years ago — a dark orange capsule he takes twice a day.”
16-year-old finds a new way to detect cancer
(CBS News) “In our "Young Innovators" series, we've been featuring young people trying to change the world. This time, we spotlight Jack Andraka, who started googling ways to prevent cancer after losing a friend to the disease. And look where it took him.”
Lung biomarker testing hindered by insufficient tissue samples
“The biggest challenges faced in incorporating biomarker testing into the care of persons with lung cancer involve the ability to obtain tissue samples of sufficient size and quality, according to newly released survey findings. Biomarker testing, in which tissue is tested for a given genetic mutation or translocation, can be used to tailor treatment to a person's specific type of cancer.”
Study in hope
Research will look at best treatment options for advanced lung cancer
“The Callahan Cancer Center is one of four facilities participating in a new clinical research study aimed at Stage IV lung cancer patients. Enrollment will begin on July 1.”
Drugs Targeting Leukemia, Ovarian Cancer, And Lung Cancer To Begin Phase III, AstraZeneca Reports
The biopharmaceutical company, which operates in over 100 countries, has issued an update on its oncology pipeline for 2013.
“In 2013, AstraZeneca will be advancing three of its cancer drugs to Phase 3 clinical development, the global biopharmaceutical company reports. Leukemia, ovarian cancer, and lung cancer are the targets of the three compounds currently in development.”
Ultralow-dose CT bests X-Ray for lung cancer follow-up, but is it enough?
MINNEAPOLIS – “Minimal-dose computed tomography was superior to chest radiographs for surveillance after curative lung cancer resection in a randomized controlled trial involving over 300 patients.”
Stage 3A Lung Cancer Survival Better When Surgery Follows Chemo and Radiation
“There are several options for treatment with stage 3A lung cancer, but with options come choices. And sometimes there's no clear cut direction as to which choice is best. For example, stage 3A non-small cell lung cancer is often treated with a combination of surgery, chemotherapy, and radiation therapy, but the proper order of these treatments has been debated.”
